On June 17, the Supreme Court ruled that pay-to-delay settlements in Hatch-Waxman cases are subject to antitrust scrutiny.
It’s a green light for Federal Trade Commission enforcement. As many as 40 deals done in 2012 can be considered pay-to-delay, up from 28 the year before. Because there is no statute of limitations, the FTC has said it can make you investigate retroactively.
Mark your calendar for Tuesday, Oct. 15, when the FTC’s top enforcement officer and two stars of the Washington healthcare antitrust bar engage over the present — and future — of drug patent settlements.
Without ever leaving your office, you’ll have a ringside seat as the FTC’s Markus Meier discloses — and debates — FTC enforcement policy with: Seth Silber, Partner, Wilson Sonsini Goodrich & Rosati PC (Conference Chair); and Jeff Brennan, Partner, McDermott Will & Emery LLP.
For years, the federal courts have wrestled with pay-to-delay deals. The FTC has argued they almost surely harm competition and therefore violate antitrust laws. Now the Supreme Court has ruled 5-3 in the FTC’s favor, creating a new playing field.
This virtual conference brings you up-to-the-minute information, alerting you to FTC strategy and tactics and helping unravel legal tangles. You’ll discover answers to such key questions as:
You’ll discover what the Actavis decision really says … What to do if you’re in the middle of structuring a patent deal right now … whether no-authorized-generic deals are on the table or out the window.
You participate from the convenience of your conference room, auditorium or very own desktop. No planes, no hotels, no precious time away from work and family – just 2 1/2 hours of insights and guidance via computer.
Yes, interactive. Submit questions in real time via email. You’ll get answers back by the time the session ends.
And here’s more good news: Enlist your entire team at no extra cost. One low registration fee covers every participant at your location. It’s easy to add additional locations too, at bargain rates. Simply call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about multisite discounts.
The FTC says many pay-to-delay cases have no statute of limitations — meaning the agency can investigate and prosecute cases long considered closed. If drug patents are your life’s blood, you owe it to yourself — and your team — to attend.
Here’s How It Works
Twenty-four hours prior to the Virtual Conference on Tuesday, attendees will receive all presentations.
Then, just log on to the Virtual Conference website and dial a toll-free number, both provided in your registration confirmation. And relax. That’s all there is to it.
Key people throughout your company will benefit from taking part in this event. Best of all, everyone can do so at a cost that won’t break the budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word.
Don’t take unnecessary risks. Sign up today for this timely learning event.